Literature DB >> 3286631

The biochemical basis of mitochondrial diseases.

H R Scholte1.   

Abstract

Dysfunctioning of human mitochondria is found in a rapidly increasing number of patients. The mitochondrial system for energy transduction is very vulnerable to damage by genetic and environmental factors. A primary mitochondrial disease is caused by a genetic defect in a mitochondrial enzyme or translocator. More than 60 mitochondrial enzyme deficiencies have been reported. Secondary mitochondrial defects are caused by lack of compounds to enable a proper mitochondrial function or by inhibition of that function. This may result from malnutrition, circulatory or hormonal disturbances, viral infection, poisoning, or an extramitochondrial error of metabolism. Once mitochondrial ATP synthesis decreases, secondary mitochondrial lesions may be generated further, due to changes in synthesis and degradation of mitochondrial phospholipids and proteins, to mitochondrial antibody formation following massive degradation, to accumulation of toxic products as excess acyl-CoA, to the depletion of Krebs cycle intermediates, and to the increase of free radical formation and lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286631     DOI: 10.1007/bf00768393

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  247 in total

1.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

2.  Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debré syndrome, and a defective respiratory chain in voluntary striated muscles.

Authors:  J P Van Biervliet; L Bruinvis; D Ketting; P K De Bree; C Van der Heiden; S K Wadman
Journal:  Pediatr Res       Date:  1977-10       Impact factor: 3.756

3.  Familial "mitochondrial" myopathy. A myopathy associated with disordered oxidative metabolism in muscle fibres. 2. Biochemical findings.

Authors:  M Worsfold; D C Park; R J Pennington
Journal:  J Neurol Sci       Date:  1973-07       Impact factor: 3.181

4.  Reversibility of the inhibition of cytochrome c oxidase by reticulocyte lipoxygenase.

Authors:  R Wiesner; P Ludwig; T Schewe; S M Rapoport
Journal:  FEBS Lett       Date:  1981-01-12       Impact factor: 4.124

5.  Glutaryl-CoA dehydrogenase activity determined with intact electron-transport chain: application to glutaric aciduria type II.

Authors:  E Christensen
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

6.  Combined partial deficiency of muscle carnitine palmitoyltransferase and carnitine with autosomal dominant inheritance.

Authors:  V Ionasescu; G Hug; C Hoppel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

7.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Decreased transport of ornithine across the inner mitochondrial membrane as a cause of hyperornithinaemia.

Authors:  F A Hommes; C K Ho; R A Roesel; M E Coryell; B A Gordon
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  Follow-up study of a myopathy with loosely coupled mitochondria.

Authors:  A E Meijer; G K van Wijngaarden
Journal:  Pathol Res Pract       Date:  1983-08       Impact factor: 3.250

10.  Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment.

Authors:  N Bresolin; L Freddo; V Tegazzin; L Bet; M Armani; C Angelini
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

View more
  17 in total

Review 1.  Bacterial NADH-quinone oxidoreductases.

Authors:  T Yagi
Journal:  J Bioenerg Biomembr       Date:  1991-04       Impact factor: 2.945

Review 2.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 3.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

4.  Detection of early ischemic damage by analysis of mitochondrial function in skinned fibers.

Authors:  L Kay; A Rossi; V Saks
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

5.  Adenine nucleotide translocator deficiency in muscle: potential therapeutic value of vitamin E.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; J A Jeneson; W Ruitenbeek; R J Wanders; N G Abeling; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies.

Authors:  A M Stadhouders; P H Jap; H P Winkler; H M Eppenberger; T Wallimann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 7.  Prospects for the genetics of human longevity.

Authors:  F Schächter; D Cohen; T Kirkwood
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

Review 8.  The development of mitochondrial medicine.

Authors:  R Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Oxidative stress disturbs energy metabolism of mitochondria in ethanol-induced gastric mucosa injury.

Authors:  Jin-Shui Pan; Shao-Zhen He; Hong-Zhi Xu; Xiao-Juan Zhan; Xiao-Ning Yang; Hong-Min Xiao; Hua-Xiu Shi; Jian-Lin Ren
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 10.  Problems with the biochemical diagnosis in mitochondrial (encephalo-)myopathies.

Authors:  J M Trijbels; H R Scholte; W Ruitenbeek; R C Sengers; A J Janssen; H F Busch
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.